Rimactazid 300 is a combination medication primarily used in the treatment of tuberculosis (TB), an infectious disease caused mainly by the bacterium Mycobacterium tuberculosis. This medication combines two active ingredients, Rifampicin (Rifampin in the US) and Isoniazid, which work together to kill or stop the growth of the bacteria responsible for TB. Rifampicin works by inhibiting the synthesis of bacterial DNA, while Isoniazid interferes with the production of mycolic acid, a component necessary for the bacterial cell wall. The "300" in Rimactazid 300 typically refers to the dosage strength of the components, but it's essential to follow a healthcare provider's instructions regarding dosage and duration of treatment to effectively combat the infection and prevent the development of drug-resistant bacteria.